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Immunological  specificity  for delayed skin  reactions,  as  well  as  for circulating 
antibody,  has  been  investigated  with  many  haptens  coupled  to  antigenic  protein 
carriers  (1). With these antigens,  hapten-specific antibodies  were formed consistently, 
whereas delayed reactions were produced only with the immunizing antigen and not 
with conjugates  of the same hapten with a different cartier protein. Thus, there was 
marked carrier specificity for delayed hypersensitivity reactions, as opposed  to the 
hapten  specifiicty  of antibody-induced reactions  (2,  3).  In  contrast to  this,  when 
arsanilic acid as the hapten is coupled to an apparently non-antigenic  carrier such as 
polytyrosine, the specificity  for delayed hypersensitivity is directed predominantly 
towards the hapten alone (4). Further confirmation  of the specificity of these reac- 
tions was shown by the successful desensitization  achieved with a variety of conju- 
gates of arsanilic acid  (5). Because  of the hapten-specific nature of this phenomeon, 
it was felt that the same system would provide a useful tool to investigate the specific- 
ity of immunologic unresponsiveness or tolerance. 
A  further advantage of polytyrosine-azobenzenearsonate as  an  antigen for 
the study of specificity in unresponsiveness is  that the sole determ{nant on the 
molecule for delayed reactions  and  circulating  antibody is  the  azobenzene- 
arsonate  (ABA) group attached to tyrosine and that the specificity for unre- 
sponsiveness would presumably also be directed towards this group. It seemed 
possible that even tyrosine-azobenzenearsonate itself might induce unrespon- 
siveness in the newborn guinea pig. The following results indicate that unre- 
sponsiveness for delayed hypersensitivity to the ABA determinant is specific 
for the determinant and is not only induced by the complete antigen but also 
by the hapten and by conjugates of arsanilic acid and unrelated carriers. 
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Materials and Methods 
Polytyrosine-Azobenzenearsonate  (ABA-polytyr)  and  Polyhistidine-Azobenzenearsonate 
(ABA-polykist).--Arsanilie  acid was diazotized in the cold with nitrous acid and conjugated 
to either polytyrosine or polyhistidine (purchased from New England Nuclear Corporation, 
Boston) in alkaline solution in a ratio of 1 arsanilate group to 5 tyrosine or histidine residues. 
The reactions were allowed to proceed for 2 hours, at which time the resulting dark red solu- 
tions were dialyzed overnight against r~mnlng water. 
Bovine  Serum  Albumin-Asobenzenearsonate (ABA-BSA):  Guinea Pig  Serum  Albumin- 
Azobenzenearsonate (ABA-GSA).--Bovine serum albumin (BSA), crystallized, was obtained 
from Pentex, Incorporated, Kankakec, Illinois. Guinea pig serum albumin (GSA) was pre- 
pared by repeated precipitation with Na2SO4.  After electrophoresis on cellulose acetate, a 
very faint ~-globulin band was visible in addition to the main albumin band. Arsanilic acid 
was conjugated to BSA by reaction of 10  --5 moles of the diazotized acid per 10 mg of protein 
(70 ABA/BSA molecule). The ABA-GSA used for skin testing was prepared by coupling a 
large excess of arsanilic acid  (4 X  10  -~ moles per mg N  protein). Conjugation was allowed 
to proceed in ice cold alkaline solution (pH 9-10) overnight and the deeply colored products 
dialyzed against running tap water. All transfers were done quantitatively, and final concen- 
trations of conjugated proteins were determined by assuming no loss during the conjugation 
process. 
Preparation of Small Conjugates.--In order to synthesize conjugates of single amino acids 
structurally similar to the polymers, N-acetylated amino acids were used. This insured that 
coupling of the ABA group occurred directly to the aromatic ring and  not on the a-amino 
group. The position of the aso link was then identical with that in the amino acid polymers 
and protein conjugates. 
N-aeetyltyrosin  and  N-acetylhistidine  were  purchased  from  California  Biochemical 
Research Company, Los Angeles. Tyrosyltyrosine was  purchased from  the New  England 
Nuclear Corporation, and was acetylated by mixing 10  -4 moles with 5 ml of half saturated 
sodium acetate and slowly adding excess acetic anhydride with stirring. The reaction mixture 
was allowed to stand overnight in the cold and then made alkaline with NaOH. 
One mole of diazotized arsanille acid was added to one mole (plus 10 per cent excess)  of 
N-aeetyltyrnsine and .N-acetylhistidine. Two  moles were added per mole of the N-aeetyl- 
tyrosyltyrosine. After standing overnight at pH 9-10, the deeply colored preparations were 
purified by alternate precipitation with acid and resolubilization with alkali. These conju- 
gates are designated ABA-tyr,  ABA-hist, and diABA-dityr respectively. 
Induction of Unresponxiveness.--White male guinea pigs, less than 24 hours old, were in- 
jected with 1 ml of the conjugates in saline. This volume was distributed between the four 
foot-pads, two intramuscular sites, and in the peritoneum. As the newborn guinea pigs were 
weaned immediately, there was considerable mortality in the first few weeks from this, as 
well as the possible toxicity of the arsanilate compounds. Even in the control groups, ap- 
proximately 10 to 30 per cent of the animals died in the first few weeks of life. 
Immunization  and Testing.--At 6 to 8 weeks the surviving guinea pigs were immunized 
with antigens emulsified in an equal volume of light mineral oil-arlaeel A mixture (8.5  ml to 
1.5 ml) containing 5 mg of killed mycobacterium per mh A total of 0.1 ml of this emulsion 
containing 100 #g of the antigen was distributed among the four foot-pads. Two weeks later, 
skin tests were done with the heterologous carrier conjugate, ABA-GSA, to test for hapten- 
specific delayed sensitivity. Five days later, the guinea pigs were bled, and all experiments 
were terminated 2 to 3 days later with a test for systemic anaphylaxis by intracardiac injec- 
tion of a  1.0 ml of a solution of ABA-BSA (1 mg/ml). Anaphylaxis was only recorded if it was 
observed within 5 minutes after the injection. Hemagglutination tests were carried out on the 
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:RESULTS 
As both ABA-polytyr and ABA-polyhist consistently produced hapten-spe- 
cific delayed hypersensitivity reactions in the adult guinea pig, it seemed likely 
that they would also effectively  produce unresponsiveness in the newborn. These 
antigens were given to groups of 1-day-old guinea pigs in a dose containing 2 X 
10-  6 moles of ABA per newborn animal. The delayed responses were examined 2 
weeks after immunization of the 5-week-old animals with either of these anti- 
gens, and the results axe given in Table I. All animals given ABA-polytyr at 
birth were rendered completely unresponsive, as neither ABA-polytyr nor ABA- 
polyhist were able to produce sensitization in the adults. On the other hand, 
TABLE I 
Unresponsiveness to  Hapten-Spexif~  Delayed Hypersensitivity  Induced  by  Arsanilate  Poly- 
amino Acid Conjugates 
At birth 2 X 10  -e moles  ABA]  Immunized  at 5 weeks I00 ~g/  Delayed reactions  in mm of  guinea pig  guinea pig  induration and erythema  to: 5  t~g  N ABA-GSA 
ABA-polytyr 
ABA-polyhist 
Nothing 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
0, 0, 0 
0, 0, 0, 0 
9, 15,  10, 0 
11, 0, 12, 11 
23, 20, 22, 18 
15, 13, 22, 18 
when ABA polyhist was given at birth, the unresponsiveness was only partial 
in the 7-week-old animals, as they retained or had regained some ability to elicit 
hapten-specific delayed reactions following immunization with both antigens. 
The skin reactions, though, were not as great as those of the control group which 
had not been injected at birth, although all lesions were specific for the hapten. 
The possibility then arose that the hapten alone might be capable of playing 
the same role in the newborn, since the delayed reactions suppressed by the com- 
plete antigens were hapten specific. Various simple haptens comprising arsanilic 
acid conjugated to a  single tyrosine or histidine group and the slightly more 
complex bivalent molecule diABA-dityr, as well as unconjugated axsanilic acid 
itself, were given to 1-day-old guinea pigs. In Table II, the results of skin tests 
made on guinea pigs, each given 2 X  10  -6 moles of ABA at birth, are presented. 
In this experiment, the animals were 6 weeks old when immunized and 8 weeks 
old when skin tested. 
Ars~nilic acid itself was incapable of creating unresponsiveness to delayed hy- 
persensitivity reactions, despite the large dose given at birth, which was quite 
toxic. Of 22 animals injected, only 9 survived for immunization. 508  DELAYED  ttYPERSENSITIVITY.  IV 
ABA-tyr induced partial unresponsiveness to delayed reactions produced by 
immunization with a conjugate of the homologous amino acid polymer, ABA- 
polytyr. Only 2 of 5 animals produced even small lesions. When the heterologous 
amino acid polymer ABA-polyhist was the immunizing antigen, the skin lesions 
formed in all 5 animals were comparable in size to those of the control goup. 
Similarly, ABA-hist initiated unresponsiveness in 2 of 4 animals immunized 
with the homologous amino acid polymer as carrier, ABA-polyhist. Again, this 
unresponsiveness was completely broken in the other 6 animals immunized with 
the heterologous polymer of tyrosine conjugated to arsanilic acid. The divalent 
TABLE II 
Induction  of  Unresponsiveness  with  the  Low Dose  of Arsanilic  Acid  Conjugates  (2 X  10  -6 
moles  ABA  in  Guinea  Pigs  Immunized  ag  6  Weeks 
At birth 2  X  10  -s moles ABA/  Immunized at 6 weeks 100 #g/  Delayed  reactions  in mm to 5 #g 
guinea pig  guinea pig  N  ABA-GSA 
Arsanilic acid 
ABA-tyr 
ABA-hist 
di-ABA-dityr 
Nothing 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
AB A-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
15, 9, 18, 15, 14 
10, 12, 10, 14 
o, 9, o, o, 8 
15, 13, 14, 10, 10 
11, 14, 15, 15, 9, 14 
12, o, 11, 0 
9,7,0 
8, 6, 0, 0 
13, 14, 13, 13 
14, 14, 10, 13 
hapten diABA-dityr created unresponsiveness, too, and this, in contrast to the 
monovalent haptens,  was equally effective against immunization by both the 
homologous and heterologous amino acid polymer conjugates.  Four of 7 ani- 
mals formed detectable skin lesions, but these were considerably smaller than 
those in the control animals. 
Since 2 )<  10  -6 moles of ABA-conjugate at birth induced only partial unre- 
sponsiveness, a fivefold larger dose of the two monovalent and the divalent hap- 
ten was tried in order to enhance tolerance to the arsanilate group. In this ex- 
periment, arsanilic acid itself was not given, as the larger dose was too toxic. The 
results of tests done on animals given conjugates containing 10  -5 moles of ABA 
at birth and immunized at 6 weeks are presented in Table III. This larger dose of 
the monovalent haptens at birth induced complete unresponsiveness in 4 of the 
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tially unresponsive. Six of 8 guinea pigs given ABA-dityr at birth were totally 
unresponsive,  and the remaining 2 were partially so. The unresponsiveness is 
emphasized by the large lesions achieved in control animals in this experiment. 
Furthermore,  in  all groups  the heterologous  amino  acid  polymer in  the  im- 
munizing antigen seemed to be no more effective at breaking this unresponsive- 
ness  than  the homologous polymer, in  contrast  to results  obtained with  the 
lower level of conjugate injection.  All animals gave good delayed hypersensi- 
tivity reactions to old tuberculin, demonstrating the specificity of the suppres- 
sion produced. 
A  further experiment was carried out on guinea pigs given the larger dose, 
TABLE III 
Induction  of Unresponsiveness  with the High Dose  of Arsanilic Acid  Conjugates  (10  -s moles 
ABA  in  Guinea  Pigs  Immunized  at  6  Weeks 
At birth 10  -5 moles  ABA/  Immunized  at 6 weeks 100  Delayed  reaction in mm  Average reac- 
guinea pig  ~g/guinea pig  to 5  ~g N ABA-GSA  tion to O.T.  1:500 
ABA-tyr 
ABA-hist 
di-ABA-dityr 
Nothing 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
5, 0, 5, 11 
0, 5, 0, 0 
0, 5, 7, 19 
0, 0, 15, 0 
0, 0, 6, 0 
0, 0, 0, 10 
18, 17, 12, 20 
19, 17, 13, 12, 15 
17 
17 
17 
17 
16 
15 
16 
18 
10  °5 moles of ABA, at birth and immunized 2 weeks later than in the previous 
experiment, at 8 weeks of age, to determine the duration of unresponsiveness. 
The results given in Table IV show that unresponsiveness could be more readily 
broken at this age in animals given the monovalent haptens at birth and that 
both immunizing antigens were equally effective. However, 6 of the 7 guinea 
pigs given the divalent hapten di-ABA-dityr were still unresponsive at 8 weeks 
to the arsanilate grouping. Once again, the large lesions induced by old tuber- 
culin in all the animals demonstrate the specificity of the unresponsiveness pro- 
duced.  The duration  of unresponsiveness was also studied in newborns given 
one of two doses of ABA-polytyr containing either 10  -s moles or 100 ~ moles of 
ABA. Another group was given ABA-BSA in a concentration of 100  5 moles of 
ABA per animal. A fourth group was given 10 mg of polytyrosine alone at birth, 
and all the animals were immunized at 8 weeks. The results from this experi- 
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TABLE IV 
Induction of Unresponsiveness with the High Dose of Arsanilic Acid  Conjugates (10  -5 moles 
ABA) in Guinea Pigs Immunized at 8 Weeks 
At birth  10  -5 moles ABA/ 
guinea pig 
ABA-hist 
ABA-tyr 
di-ABA-dityr 
Nothing 
Immunized at 8 weeks 100 
~g/guinea pig 
ABA-polytyr 
ABA-polyhist 
AB A-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
Delayed reactions in ram 
to 5 ug N  ABA-GSA 
0, 14, 15, 14, 18 
11, 12, 16, 11 
14, 11, 0 
12, 13, 14 
0, 0, 0, 0 
0, 0, 15 
5, 17, 16, 18 
6, 20, 19, 17 
Average reac- 
tion to O.T. 
1:500 
15 
16 
18 
20 
17 
18 
17 
17 
TABLE V 
Absence of Carrier Specificity in Unresponsiveness to ttapten-Specific Ddayed Hypersensitivity 
Induced by Conjugates of Arsanili¢ Acid 
Immunized at 8 weeks (100 ~g/  Delayed reactions in mm to 
At birth  guinea pig)  5 ~g NABA-GSA 
ABA-polytyr (10  4  moles ABA 
ABA-polytyr (10  -e moles ABA 
ABA-BSA (10  -s moles ABA) 
polytyrosine (10 mg) 
Nothing 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
ABA-polytyr 
ABA-polyhist 
0, 0, 0 
0, 0, 0, 0, 0, 0, 0, 0 
0, 0, 0, 0, 0 
14, 12, 15 
0, 0, 0, 0, 0, 0 
0, 0, 0, 0, 0, 0 
20, 15, 19, 18 
18, 21, 19 
15, 8, 16, 23, 20, 18 
10, 20, 20, 18, 19, 14 
ABA-polytyr given to newborns at a dose of 10  -5 moles of ABA rendered the 
animals still unresponsive to both immunizing antigens at 8 weeks. By this time, 
however,  animals given the tenfold lower dose of ABA-polytyr. (10- 8 moles of 
ABA) at birth, had become only partially unresponsive. The pattern of break- 
through  was similar to that seen in animals given the monovalent haptens  at 
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ABA-polyhist broke through the unresponsiveness in all 3 animals,  whereas, the 
5 animals immunized with ABA-polytyr remained tolerant. 
Each of 12 guinea pigs given (at birth) 10  -s moles of ABA conjugated to the 
unrelated carrier BSA were still unresponsive to delayed hypersensitivity at 8 
weeks,  whether  the immunizing  antigen  was ABA-polytyr or ABA-polyhist. 
Conversely, 10 mg of the carrier polytyrosine itself given at birth had no effect 
on suppression of delayed reactions in the adult, even when the ABA-polytyr 
was the immunizing  antigen,  thus confirming  the hapten specificity for unre- 
sponsiveness to delayed reactions in these experiments. 
Studies were made on each animal for systemic anaphylaxis and hemaggluti- 
hating  antibody in all  the experiments above, as described in Materials and 
Methods. 
In general, however, antibody production following immunization with ABA- 
polytyr or ABA-polyhist was so poor and variable that no conclusive evidence 
concerning  unresponsiveness in respect to hapten-specific antibody formation 
was obtained, and these results will not be discussed further. 
DISCUSSION 
The  specificity of unresponsiveness  to  antibody formation  has  been well 
studied (6) and appears to be a function of all the separate determinants on a 
single  antigen  molecule.  Unresponsiveness has  been  successfully induced  in 
guinea pigs by the administration  of a single injection of a protein antigen at 
birth  (7). Attempts to produce unresponsiveness to some hapten-protein con- 
jugate in guinea pigs by a single injection at birth were unsuccessful; the tol- 
erant  state  was,  however,  achieved  when  these  antigens  were  given  to 
the  foetuses in  utero  sometime  before parturition  (8).  Unresponsiveness  to 
haptens has also been produced in rabbits by neonatal injection of the uncon- 
jugated carrier  but not by injection of the hapten alone  (9). These results sug- 
gest a significant  role for the carrier in the production of hapten-specific unre- 
sponsiveness. 
In a more direct fashion, the carrier protein has been shown (1) to play a de- 
cisive role in the development of delayed sensitivity in. most hapten-conjugate 
systems studied.  Similarly,  the development of unresponsiveness  to delayed 
hypersensitivity with  hapten-protein  conjugates may be inferred  to require 
carrier participation. Thus, Chase (10) demonstrated that guinea pigs rendered 
unresponsive by feeding of dinitrochlorobenzene  were unsensitized by inocula- 
tion of the specific hapten in incomplete adjuvant when tested by dermal, ap- 
plication of the allergen.  Immunization with a conjugate of the hapten and a 
heterologous protein, however, produced a delayed sensitivity to the conjugate. 
Salvin and Smith (11) produced unresponsiveness in guinea pigs with hapten- 
protein conjugates and cyclophosphamide treatment and concluded from their 
studies that while the specificity of antibody is directed towards small molecular 512  DELAYED  ttYPERSENSI~VITY.  IV 
groupings, and the specificity of delayed hypersensitivity is directed towards 
larger molecular groupings, the specificity of unresponsiveness may be oriented 
towards the whole antigen molecule. The difficulty inherent in any such analysis 
stems from the uncertainty as to the nature and number of antigenic groupings 
concerned in reactions with the usual hapten-protein conjugates (12). Since such 
antigens usually consist of hapten coupled to a variety of amino acid residues, 
each in turn adjacent to an equally diverse assortment of amino acids, it be- 
comes apparent that a most complex array of antigenic determinants may be 
present. In addition, it has been shown recently (13) that guinea pigs immunized 
with hapten-protein conjugates make a diversity of antibodies, some directed 
towards determinants including a portion of the carrier molecule as well as the 
hapten.  Conceivably, therefore, the differences in specificity of antibody, de- 
layed hypersensitivity, and unresponsiveness may be more apparent than real 
and must be analyzed in terms of all the determinant groups involved in any 
particular response. 
In contrast to these complex systems, a conjugate such as ABA-polytyr repre- 
sents a useful simplification, since there are relatively few determinants towards 
which an immune response may be directed. These most probably would con- 
sist of the azobenzenearsonate group, plus tyrosine, with perhaps some multiple 
of either of these also being a possibility. As far as delayed hypersensitivity is 
concerned, the existing evidence makes it appear likely that the azobenzene- 
arsonate group acts as the major component of the antigenic determinant. In 
particular: (a) delayed hypersensitivity produced by immunization with ABA- 
polytyr, ABA-polyhist, or ABA-polylysine may be elicited by any conjugate 
prepared with an unrelated carrier  (4); and (b)  delayed hypersensitivity pro- 
duced by immunization with ABA-polytyr may be suppressed by conjugates of 
heterologous amino acids or carriers (5). 
The results presented in this paper suggest that the unresponsiveness pro- 
duced in respect to delayed hypersensitivity follows a similar pattern of speci- 
ficity. Thus, a  sutficiently high concentration of ABA-tyr, di-ABA-dityr, and 
ABA-polytyr could produce a specific suppression of delayed sensitivity, even 
when immunization was attempted with the conjugate of the heterologous car- 
rier, ABA-polyhist. Similarly, ABA-hist or ABA-polyhist could produce unre- 
sponsiveness  (albeit  not  as  uniformly) to  immunization with  ABA-polytyr. 
Arsanilic acid itself at the only dose level used was without apparent effect. 
These results, therefore, suggest that the unresponsiveness as well as the de- 
layed reaction are largely directed towards the azophenylarsonate group,  the 
only common determinant of the conjugates used. 
However, at lower dose levels, evidence for a slight but significant contribu- 
tion by the amino acid could be seen (Table II). Here the unresponsiveness in- 
duced by ABA-tyr and ABA-hist was broken by immunization with ABA con- 
jugated to the hetrologous amino acid polymer but less so in animals immunized VALERIE  E.  JONES  AND  SIDNEY  LESKOWITZ  513 
with a conjugate of the homologous amino acid polymer. This was even more 
clear cut in the use of the low dose of ABA-polytyr to produce unresponsiveness 
(Table V). At 8 weeks all animals immunized with the heterologous conjugate 
produced excellent hapten-specific delayed sensitivity, while none of the ani- 
mals  immunized with  the  homologous conjugate responded.  The  conjugate 
ABA-BSA proved to have excellent capacity for suppression. Since this conju- 
gate contains many ABA-tyr and ABA-hist groupings, it is not clear whether 
its effectiveness is also attributable to contributions by the amino acid residues. 
It would appear, therefore, that at high dose levels unresponsiveness is retained 
for all challenge antigens, while at lower dose levels breakthrough of tolerance is 
achieved first with heterologous carriers. 
The injection of the carrier polytyr itself seemed to be completely without 
effect on the development of hapten-specific delayed sensitivity following im- 
munization with ABA-polytyr. These results, in contrast to those of Boyden and 
Sorkin (9), may perhaps be taken as further evidence that in this system the 
azobenzenearsonate group represents a  complete determinant, whereas other 
hapten-conjugate systems require significant contributions by the carrier to the 
determinants. 
The ability of the small monovalent conjugates to produce a long lasting un- 
responsiveness in respect to delayed sensitivity was surprising in view of pre- 
vious findings that they produced only a  transient suppression in animals al- 
ready sensitized (5).  It was expected that in the former case the small conju- 
gates would be rapidly cleared from the guinea pigs, as was inferred in the latter 
phenomenon. In fact, the observation that the larger conjugate diABA-dityr 
had a more profound and longer acting effectiveness in suppression, while ABA- 
polytyr had a still more profound effect, suggested that the size of a conjugate 
played some role in its ability to produce suppression, most likely related to its 
ability to persist. Thus, it has been shown that arsanilic acid is rapidly elimi- 
nated  from  mice,  while  the  large  conjugate  ABA-BSA  is  taken  up  by 
the reticulo-endothelial system and retained for considerable periods (14). 
Alternatively, valence of the molecule may be of importance to its effective- 
ness in suppressing sensitization. It is known that monovalent haptens will re- 
versibly inhibit antibody-mediated (15), as well as cell-mediated, reactions (5). 
Polyvalent conjugates, on the other hand, react with and use up the existing 
supply of antibody or sensitized cells and produce a much longer state of unre- 
sponsiveness. If tolerance to delayed sensitivity depended on the using up of 
cells or active sites in a manner akin to the precipitation of antibody, this would 
offer an alternative basis than persistence for the greater efficacy of the larger 
conjugates. 
Nevertheless, there seemed to be a remarkable discrepancy between the time 
(5 days) during which 10  -5 moles of ABA-tyr was effective in suppressing de- 
layed sensitivity in a sensitized animal and the time (6 weeks) over which the 514  DELAYED  ttYPERSENSITIVITY.  IV 
same dose would remain effective in producing tolerance to delayed sensitivity 
when given to a newborn guinea pig. One possible explanation may lie in the 
different routes of administration of conjugate used to study these phenomena. 
Tolerance in the newborn was produced by foot-pad, intramuscular and intra- 
peritoneal injections, which might presumably slow  down the elimination of 
the conjugate in contrast to that occurring in the previously sensitized animal 
where conjugates were given by intracardiac injection. However, preliminary 
results in  sensitized animals indicate that  conjugates given in  the foot-pad, 
intramuscularly and intraperitoneally are still only effective for 5 days. 
It would, therefore, seem that a more fundamental difference in effect is in- 
volved. The most plausible explanation at this stage is that two different target 
cells are involved in the reaction with ABA-tyr. In the one case a precursor cell 
is so affected by contact with the conjugate that it is rendered unresponsive or 
destroyed. Sufficient time must now elapse before new cells appear or old cells 
can recover to respond to an immunologic stimulus, and this process requiring 
weeks would determine the duration of tolerance. On the other hand, previously 
sensitized cells reacting reversibly with the monovalent conjugate are inhibited 
from reacting with the antigen. When the conjugate is cleared,  a process re- 
quiring only days, the sensitized cells are free to react with antigen. 
The present results  demonstrate  that tolerance  to azobenzenearsonate di- 
rected delayed hypersensitivity may be effectively produced by a  variety of 
conjugates of the azobenzenearsonate group. In general, the larger conjugates 
were more efficient than the small conjugates in producing and maintaining 
this tolerance. 
Furthermore, it appears that the determinant group present in the conju- 
gate given at birth must have the same, or a  broader, specificity than that 
present on the sensitizing antigen in order to induce a long lasting unrespon- 
siveness to  delayed hypersensitivity reactions.  It is  not yet possible  to  say 
whether unresponsiveness in this system is dependent on persistence or valence 
of conjugate. 
SUMM~RY 
Injections of various conjugates of arsanilic acid into newborn guinea pigs 
produced a specific tolerance in respect to subsequent development of hapten- 
specific delayed hypersensitivity. In general, larger polyvalent conjugates pro- 
duced longer  lasting  and  more  profound  suppression  of  delayed sensitivity 
than did the smaller ones. Carrier injections alone were ineffective. At lower 
doses of conjugate, breakthrough of tolerance occurred first with animals im- 
munized with the heterologous carrier conjugate. 
The duration of tolerance produced by injection of monovalent conjugates 
into neonates is in contrast to the transient inhibition produced by the same 
conjugates in previously sensitized animals, suggesting that  different target 
cells may be involved in these two phenomena. VALERIE E. JONES AND SIDNEY LESKOVc-ITZ  515 
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